Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection
Stopped PI left institution
Conditions
Interventions
Sponsor
Johns Hopkins University
Collaborators